Watch ACHV. Know when insiders buy.
One email the day a filing lands. Free.
Work order
45
WATCH · insiders 42, shorts 48
Insiders, 90 days
−$175K
net selling · 0 buys, 1 sell
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $873.6MP/E —DIV YIELD —FCF YIELD —REV TTM —NET INCOME −$114MNET CASH —52W 2.65 – 8.53SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | — | — | — | — | −$74.8M | — | -0.80 | −$10.8M | — | — | Aug 11 |
| Q1 2026 · Mar 31 | — | — | — | — | −$10.2M | — | -0.19 | −$6.9M | — | — | Aug 11 |
| Q4 2025 · Dec 31derived | — | — | — | — | −$14.7M | — | -0.26 | −$18M | — | — | Mar 24 |
| Q3 2025 · Sep 30 | — | — | — | — | −$14.4M | — | -0.28 | −$11.3M | — | — | Nov 6 |
| Q2 2025 · Jun 30 | — | — | — | — | −$12.7M | — | -0.37 | −$9.1M | — | — | Aug 11 |
| Q1 2025 · Mar 31 | — | — | — | — | −$12.8M | — | -0.37 | −$11.1M | — | — | Aug 11 |
| Q4 2024 · Dec 31derived | — | — | — | — | −$12.4M | — | -0.36 | −$9.2M | — | — | Mar 24 |
| Q3 2024 · Sep 30 | — | — | — | — | −$12.5M | — | -0.36 | −$10.4M | — | — | Nov 6 |
| Q2 2024 · Jun 30 | — | — | — | — | −$8.5M | — | -0.25 | −$4.9M | — | — | Nov 6 |
| Q1 2024 · Mar 31 | — | — | — | — | −$6.5M | — | -0.26 | −$5.3M | — | — | Nov 6 |
| Q4 2023 · Dec 31derived | — | — | — | — | −$5.5M | — | -0.24 | −$4.4M | $6K | −$4.4M | Mar 24 |
| Q3 2023 · Sep 30 | — | — | — | — | −$7.1M | — | -0.34 | −$5.1M | — | — | Nov 7 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | — | — | — | −$54.6M | — | -1.25 | −$49.5M | $3K | −$49.5M | — | — |
| FY2024 · to Dec 31 | — | — | — | −$39.8M | — | -1.24 | −$29.8M | — | — | — | — |
| FY2023 · to Dec 31 | — | — | — | −$29.8M | — | -1.50 | −$24.5M | $21K | −$24.5M | — | — |
| FY2022 · to Dec 31 | — | — | — | −$42.4M | — | -4.00 | −$37.6M | — | — | — | — |
| FY2021 · to Dec 31 | — | — | — | −$33.2M | — | -4.08 | −$29.4M | — | — | — | — |
| FY2020 · to Dec 31 | — | — | — | −$14.7M | — | -5.42 | −$13.5M | $17K | −$13.5M | — | — |
Every number comes from ACHIEVE LIFE SCIENCES, INC.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.